Global Frozen Shoulder Market, By Treatment Type (Medication, Joint Distension, Physical Therapy, Surgery, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Frozen Shoulder Market Analysis and Size
Global frozen shoulder market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.The growth of frozen shoulder market enhanced by the growing cases of frozen shoulder which create an opportunity for the pharma companies to introduce novel therapy and increase in research and development activities. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global frozen shoulder market in the forecast period 2022-2029. The expected CAGR of global frozen shoulder market is tend to be around 10% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Frozen shoulder, also called adhesive capsulitis, is defined as idiopathic condition characterized by spontaneous stiffness and sudden or achy pain in the joint of the shoulders. It is occurring more commonly in woman at premenopausal age than man. A long period of inactivity owing to an injury, illness, or surgery also increases the chances to inflammation and adhesions, which are bands of stiff tissue.
Frozen Shoulder Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Treatment Type (Medication, Joint Distension, Physical Therapy, Surgery, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GlaxoSmithKline plc (U.S.), Contract Pharmacal Corp (U.S.), Amneal Pharmaceuticals, Inc. (U.S.), Vintage Labs (India), Dr. Reddy's Laboratories Ltd (India), Marksans Pharma (India), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (U.S.), Perrigo Company plc (Ireland), Johnson & Johnson Private Limited (U.S.)
|
|
Market Opportunities
|
|
Global Frozen Shoulder Market Dynamics
Drivers
- Rise in Elderly Population
The number of elderly people worldwide is rising at an unheard-of rate. Currently, there are 617 million persons over the age of 65 in the world, or 8.5% of the population. By 2050, the number is expected to increase to about 17 percent of the world's population, according to a recent analysis called An Aging World: 2015. (1.6 billion). Between 2015 and 2050, the number of people 80 and older is projected to more than triple, from 126.5 million to 446.6 million. In several nations in Asia and Latin America, the population of those 80 and older is expected to double by 2050.
- Rising Incidence of Shoulder Injuries
A frequent and incapacitating ailment is shoulder pain. In primary care, shoulder discomfort is reported to occur 14.7 times per 1000 patients year, with a lifetime frequency of up to 70%. Between 1 percent and 66 percent, there are wide variations in the estimated prevalence of shoulder pain. It is also common in younger age groups (adolescents aged 12–18 years, from 12–57%) and may be related to a postural relationship with increased periods of sitting and increased technology use.
Opportunities
- Rising Incidence of Diabetes
According to estimates, there will be 463 million individuals worldwide with diabetes in 2019. By 2030, that number is expected to increase to 578 million; by 2045, it will reach 700 million. Diabetes can impact the musculoskeletal system in a variety of ways. One of the bodily parts that is usually impacted is the shoulder. Adhesive capsulitis, or frozen shoulder, is one of the rheumatic diseases brought on by diabetes. The glenohumeral joint's active and passive range of motion, primarily external rotation, are severely limited and painful.
- High Prevalence of Frozen Shoulder
According to estimates, 2 to 5 percent of the general population suffers with frozen shoulder. Patients with frozen shoulder syndrome (FSS) often range in age from 40 to 60. Although the exact incidence of FSS is unknown, it is believed that 2 to 5 percent of the general population may have the disease at some point in their lifetime. There is no preference for race, and men are often less impacted than women.
Restraints/Challenges
- High Cost
The huge expenditure required for the treatment process surely hampers the market growth. Several market players make huge investments in developing new and advanced techniques to faster recovery in return, the cost is increased.
This global frozen shoulder market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global frozen shoulder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Frozen Shoulder Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
In the post-pandemic era, COVID-19 is expected to positively impact the global frozen shoulder market due to the increased pace of the treatments and reopening of hospitals for non-COVID19 patients.
Global Frozen Shoulder Market Scope
The global frozen shoulder market is segmented on the basis of treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment Type
- Medication
- Joint Distension
- Physical Therapy
- Surgery
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Frozen Shoulder Market Regional Analysis/Insights
The global frozen shoulder market is analysed and market size insights and trends are provided by treatment type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global frozen shoulder market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America represents a positive growth for frozen shoulder market throughout the forecasted period due to the global leaders in research and development activities, vulnerable aging and increased cases of frozen shoulder.
Asia-Pacific dominates the market due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Frozen Shoulder Market Share Analysis
The global frozen shoulder market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global frozen shoulder market
Key players operating in the global frozen shoulder market include:
- GlaxoSmithKline plc (U.S.)
- Contract Pharmacal Corp (U.S.)
- Amneal Pharmaceuticals, Inc. (U.S.)
- Vintage Labs (India)
- Dr. Reddy's Laboratories Ltd (India)
- Marksans Pharma (India)
- Sun Pharmaceutical Industries Ltd (India)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (U.S.)
- Perrigo Company plc (Ireland),
- Johnson & Johnson Private Limited (U.S.)
SKU-